Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.16m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Result of AGM

7 Jul 2021 12:37

RNS Number : 5000E
Maven Income & Growth VCT PLC
07 July 2021
 

 

 

Maven Income and Growth VCT PLC

 

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at First Floor, Kintyre House, 205 West George Street, Glasgow G2 2LW at 12.00 noon on Wednesday 7 July 2021, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 5 July 2021, the total number of voting rights in the Company stood at 135,928,391 and the total shares in issue were 135,928,391. The Company advises that, for the Annual General Meeting, valid proxy appointments were made in respect of 8,320,502 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and audited Financial Statements

7,909,563

293,669

22,350

94,920

8,320,502

2

To approve the Directors' Remuneration Report

7,626,458

324,505

234,277

135,262

8,320,502

3

To approve the payment of a final dividend

 

7,992,978

299,004

0

28,520

8,320,502

4

To re-elect John Pocock as a Director

 

7,782,873

302,277

119,757

115,595

8,320,502

5

To re-elect Alison Fielding as a Director

 

7,763,368

302,277

107,172

147,685

8,320,502

6

To re-elect Andrew Harrington as a Director

 

7,843,736

302,277

36,544

137,945

8,320,502

7

To re-elect Arthur MacMillan as a Director

 

7,674,870

347,764

151,437

146,431

8,320,502

8

To re-appoint Deloitte LLP as Auditor

 

7,297,482

299,004

681,872

42,144

8,320,502

9

To authorise the Directors to fix the remuneration of the Auditor

7,927,599

299,004

51,755

42,144

8,320,502

10

To renew the Company's authority to allot shares

7,493,564

283,157

489,350

54,431

8,320,502

11

To authorise the Directors to disapply pre-emption rights

7,199,751

283,157

786,351

51,243

8,320,502

12

To renew the Company's authority to purchase its own shares

7,501,189

283,157

507,636

28,520

8,320,502

13

To amend the notice period for a general meeting

7,720,493

323,418

248,071

28,520

8,320,502

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct. 

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

7 July 2021

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSMFFWEFSEDW
Date   Source Headline
26th Jun 20269:30 amRNSIssue of Equity
23rd Jun 20264:06 pmRNSAudited NAV - Dividend Investment Scheme
2nd Jun 20264:19 pmRNSAnnual Financial Report
1st May 20263:20 pmRNSTransaction in Own Shares
30th Apr 20265:09 pmRNSTransaction in Own Shares
30th Apr 202610:51 amRNSAdmission of Further Securities to Trading
29th Apr 202612:23 pmRNSIssue of Equity
27th Apr 20263:29 pmRNSUnaudited Net Asset Value and Dividend Declaration
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:17 amRNSAdmission of Further Securities to Trading
14th Apr 202611:06 amRNSIssue of Equity
8th Apr 20269:27 amRNSAdmission of Further Securities to Trading
25th Mar 202610:49 amRNSAdmission of Further Securities to Trading
24th Mar 202612:08 pmRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
29th Jan 20264:54 pmRNSTransaction in Own Shares
21st Jan 202611:01 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:39 amRNSIssue of Equity
15th Jan 202610:27 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 20269:50 amRNSIssue of Equity
14th Jan 20262:33 pmRNSUnaudited NAV - Dividend Investment Scheme
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:39 pmRNSResult of General Meeting
29th Oct 20257:00 amRNSHalf-year Report
16th Oct 20254:43 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:06 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:12 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:33 pmRNSTransaction in Own Shares
18th Jul 202510:08 amRNSIssue of Equity - Dividend Investment Scheme
16th Jul 20257:08 amRNSStatement re Offer for Subscription
11th Jul 20253:56 pmRNSStatement re Dividend Investment Scheme
11th Jul 20252:58 pmRNSStatement re Unaudited NAV and Interim Dividend
10th Jul 20252:32 pmRNSResult of AGM
28th May 20254:18 pmRNSAnnual Financial Report
7th May 20254:35 pmRNSTransaction in Own Shares
6th May 202511:51 amRNSIssue of Equity
25th Apr 20254:19 pmRNSUnaudited NAV and Proposed Final Dividend
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:15 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:02 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:23 pmRNSUnaudited Net Asset Value
29th Jan 20254:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.